XML 105 R94.htm IDEA: XBRL DOCUMENT v3.25.4
Assets Acquisition - Schedule of Fair Value of the Identifiable Assets (Details)
Dec. 31, 2025
USD ($)
Schedule of Fair Value of the Identifiable Assets [Abstract]  
Total consideration in cash $ 552,730
Assets acquired and liabilities assumed:  
Cash acquired 9
Original paid in capital paid to Hupan Pharmaceutical 276,365
Intangible assets – license of pharmaceutical distribution 418,867
Other payables (37,794)
Deferred tax liabilities (104,717)
Total assets acquired $ 552,730